Aarthi A. Jayanthan, Ph.D.
Affiliations: | 2014 | University of Calgary, Calgary, Alberta, Canada |
Area:
Oncology, Cell Biology, Molecular BiologyGoogle:
"Aarthi Jayanthan"Parents
Sign in to add mentorAru Narendran | grad student | 2014 | University of Calgary | |
(Aurora Kinase Inhibition as a Novel Therapeutic Approach for the Treatment of Refractory Pediatric and Infant Leukemia.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sharma R, Incoronato A, Zhang C, et al. (2023) Establishment of a t(11;19), KMT2A Rearranged B-ALL Cell Line for Preclinical Evaluation and Novel Therapeutics Development for Refractory Infant Leukemia. Journal of Pediatric Hematology/Oncology. 45: e750-e756 |
Kosnopfel C, Wendlinger S, Niessner H, et al. (2023) Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion. Journal of Experimental & Clinical Cancer Research : Cr. 42: 175 |
Banderali U, Jain M, Thakur S, et al. (2021) The T-type Calcium Channel Cav3.1 in Y79 Retinoblastoma Cells is Regulated by the Epidermal Growth Factor Receptor via the MAPK Signaling Pathway. Current Eye Research. 1-10 |
Thakur S, Ruan Y, Jayanthan A, et al. (2021) Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib. Current Cancer Drug Targets |
Huynh MM, Pambid MR, Jayanthan A, et al. (2020) The dawn of targeted therapies for triple negative breast cancer (TNBC): a snapshot of investigational drugs in phase I and II trials. Expert Opinion On Investigational Drugs |
Thakur S, Ruan Y, Zhang C, et al. (2020) Human SNF5 arming of double-deleted vaccinia virus shows oncolytic and cytostatic activity against central nervous system atypical teratoid/rhabdoid tumor cells. Cancer Gene Therapy |
Beeram M, Wang JS, Mina LA, et al. (2020) First-in-human phase I/Ib multicenter, open-label dose escalation study to assess safety and tolerability of PMD-026 in patients with metastatic breast cancer with expansion in metastatic triple negative breast cancer. Journal of Clinical Oncology. 38: TPS1110-TPS1110 |
Jayanthan A, Hofmann B, Meier-Stephenson V, et al. (2019) Targeted Polo-like Kinase Inhibition Combined With Aurora Kinase Inhibition in Pediatric Acute Leukemia Cells. Journal of Pediatric Hematology/Oncology |
Swift L, Jayanthan A, Ruan Y, et al. (2018) Targeting the Proteasome in Refractory Pediatric Leukemia Cells: Characterization of Effective Cytotoxicity of Carfilzomib. Targeted Oncology |
Singh A, Meier-Stephenson V, Jayanthan A, et al. (2016) In Vitro Sensitivity Profiling Of Neuroblastoma Cells Against A Comprehensive Small Molecule Kinase Inhibitor Library To Identify Agents For Future Therapeutic Studies. Current Cancer Drug Targets |